For almost five years, Schering-Plough has been waiting for its labs to produce a new hit.
Schering-Plough, which has long dominated the interferon market, sells the very similar polymer-coated interferon called Peg-Intron.
Schering-Plough 's earnings in 2003 may be little more than half what they were in 2002.
Schering-Plough is working on the control problems with the FDA and should have them resolved shortly.
The threat of generic competition against Schering-Plough's similar prescription pill, Clarinex, took care of that.
The e-mail was forwarded to Enrico Veltri, the Schering-Plough executive helping run the trial.
"We pull together panels and seek expert advice on an ongoing basis, " says Schering-Plough spokesman Davies.
One scenario has Hassan selling Schering-Plough to Merck and assuming the top job postmerger.
The Kenilworth, New Jersey-based Schering-Plough has lost two-thirds of its market value since 2000.
At the time, the marketing of the drugs was split between Schering-Plough and Merck.
Deutsche Bank does investment banking and owns 1% or more of both Merck and Schering-Plough.
But until and unless the manufacturing problems are resolved, investors should be very wary of Schering-Plough.
Invented by scientists in Schering-Plough's laboratories, it prevents cholesterol from being absorbed in the digestive system.
And Merck and Schering-Plough scrapped plans to do a Vytorin imaging trial with him.
The current gold standard of treatment is Schering-Plough's Rebetron, on the market for three years.
Unfortunately for Schering-Plough, there dont seem to be many improvements to make in the original drug.
Merck and Schering-Plough filed a new drug application for Zetia with the FDA in December 2001.
The ENHANCE study, a test of Zetia from Merck and Schering-Plough, was another surprise.
Merck and Schering-Plough disagreed with the contention that use of Zetia and Vytorin should be limited.
Merck and Schering-Plough are conducting three additional studies, involving more than 20, 000 high-risk patients.
Still, the negative result is likely to result in further scrutiny of Merck and Schering-Plough.
Schering-Plough will pay more if the gene leads to any drugs that treat prostate cancer.
Schering-Plough has only said that the FDA wants new analyses for its antipsychotic Saphris.
At Bat: CEO Kogan's great at selling drugs, but Schering-Plough can't get manufacturing straight.
Kogan, 61, has spent two decades at Schering-Plough and has been CEO for six years.
Now, the real battle begins, as Roche positions Pegasys to compete with Schering-Plough 's PEG-Intron.
"Schering-Plough is a company with a proud heritage, " Hassan said in a prepared statement.
Other companies, including Pfizer and Schering-Plough, started developing drugs to target the gene, called CCR5.
Even after profits are split 50-50 with Merck, that could mean huge earnings growth for Schering-Plough.
There, Schering-Plough and Merck seemed to have too much control over the delayed clinical trial, called ENHANCE.
应用推荐